eli lilly glp-1 pill data FDA asks for more safety on weight loss Foundayo As GLP-1 Use Expands, Long-Term

For example, data indicate that slightly more than half of patients with T2DM meet the general hemoglobin A1C goal of less than 7%, and suboptimal glycemic control continues to contribute to the development of complications like cardiovascular disease and microvascular complications

A 2025 pilot study published in PubMed confirmed short-term tolerance in 2 participants at 20mg intravenously, though the sample size remains too limited for definitive safety conclusions

B.DworkA

Without a doubt, the most critical contraindication is any known copper metabolism disorder, such as Wilsons disease

doi:10.4103/0974-7753.100090 99 Taylor, M